Anti-Inflammatory Potential of Daturaolone from <i>Datura innoxia</i> Mill.: In Silico, In Vitro and In Vivo Studies
Exploration of leads with therapeutic potential in inflammatory disorders is worth pursuing. In line with this, the isolated natural compound daturaolone from <i>Datura innoxia</i> Mill. was evaluated for its anti-inflammatory potential using in silico, in vitro and in vivo models. Datur...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_980284356dd44a8eb99a68dd1d1e9efc | ||
042 | |a dc | ||
100 | 1 | 0 | |a Muhammad Waleed Baig |e author |
700 | 1 | 0 | |a Humaira Fatima |e author |
700 | 1 | 0 | |a Nosheen Akhtar |e author |
700 | 1 | 0 | |a Hidayat Hussain |e author |
700 | 1 | 0 | |a Mohammad K. Okla |e author |
700 | 1 | 0 | |a Abdulrahman Al-Hashimi |e author |
700 | 1 | 0 | |a Wahidah H. Al-Qahtani |e author |
700 | 1 | 0 | |a Hamada AbdElgawad |e author |
700 | 1 | 0 | |a Ihsan-ul Haq |e author |
245 | 0 | 0 | |a Anti-Inflammatory Potential of Daturaolone from <i>Datura innoxia</i> Mill.: In Silico, In Vitro and In Vivo Studies |
260 | |b MDPI AG, |c 2021-11-01T00:00:00Z. | ||
500 | |a 10.3390/ph14121248 | ||
500 | |a 1424-8247 | ||
520 | |a Exploration of leads with therapeutic potential in inflammatory disorders is worth pursuing. In line with this, the isolated natural compound daturaolone from <i>Datura innoxia</i> Mill. was evaluated for its anti-inflammatory potential using in silico, in vitro and in vivo models. Daturaolone follows Lipinski's drug-likeliness rule with a score of 0.33. Absorption, distribution, metabolism, excretion and toxicity prediction show strong plasma protein binding; gastrointestinal absorption (Caco-2 cells permeability = 34.6 nm/s); no blood-brain barrier penetration; CYP1A2, CYP2C19 and CYP3A4 metabolism; a major metabolic reaction, being aliphatic hydroxylation; no hERG inhibition; and non-carcinogenicity. Predicted molecular targets were mainly inflammatory mediators. Molecular docking depicted H-bonding interaction with nuclear factor kappa beta subunit (NF-κB), cyclooxygenase-2, 5-lipoxygenase, phospholipase A2, serotonin transporter, dopamine receptor D1 and 5-hydroxy tryptamine. Its cytotoxicity (IC<sub>50</sub>) value in normal lymphocytes was >20 µg/mL as compared to cancer cells (Huh7.5; 17.32 ± 1.43 µg/mL). Daturaolone significantly inhibited NF-κB and nitric oxide production with IC<sub>50</sub> values of 1.2 ± 0.8 and 4.51 ± 0.92 µg/mL, respectively. It significantly reduced inflammatory paw edema (81.73 ± 3.16%), heat-induced pain (89.47 ± 9.01% antinociception) and stress-induced depression (68 ± 9.22 s immobility time in tail suspension test). This work suggests a possible anti-inflammatory role of daturaolone; however, detailed mechanistic studies are still necessary to corroborate and extrapolate the findings. | ||
546 | |a EN | ||
690 | |a <i>Datura innoxia</i> | ||
690 | |a daturaolone | ||
690 | |a terpenoid | ||
690 | |a anti-inflammatory | ||
690 | |a NF-<i>κ</i>B | ||
690 | |a nitric oxide | ||
690 | |a Medicine | ||
690 | |a R | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Pharmaceuticals, Vol 14, Iss 12, p 1248 (2021) | |
787 | 0 | |n https://www.mdpi.com/1424-8247/14/12/1248 | |
787 | 0 | |n https://doaj.org/toc/1424-8247 | |
856 | 4 | 1 | |u https://doaj.org/article/980284356dd44a8eb99a68dd1d1e9efc |z Connect to this object online. |